Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Caressa M Robinson"'
Autor:
Helen O. Masson, Mojtaba Samoudi, Caressa M. Robinson, Chih-Chung Kuo, Linus Weiss, Km Shams Ud Doha, Alex Campos, Vijay Tejwani, Hussain Dahodwala, Patrice Menard, Bjorn G. Voldborg, Susan T. Sharfstein, Nathan E. Lewis
Publikováno v:
bioRxiv
Understanding protein secretion has considerable importance in the biotechnology industry and important implications in a broad range of normal and pathological conditions including development, immunology, and tissue function. While great progress h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53676e5d6c116dc02cf3c9d17fd3b921
https://doi.org/10.1101/2023.05.04.539316
https://doi.org/10.1101/2023.05.04.539316
Autor:
Km Shams-Ud-Doha, Sara Petersen Bjørn, Mojtaba Samoudi, Alexandre Rosa Campos, Caressa M Robinson, Stefan Kol, Chih-Chung Kuo, Nathan E. Lewis, Linus Weiss, Bjørn G. Voldborg, Song-Min Schinn
Publikováno v:
Biotechnology and bioengineering, vol 118, iss 2
Biotechnol Bioeng
Samoudi, M, Chung Kuo, C, Robinson, C M, Shams-Ud-Doha, K, Schinn, S-M, Kol, S, Weiss, L, Petersen Bjørn, S, Voldborg, B G, Rosa Campos, A & Lewis, N E 2021, ' In situ detection of protein interactions for recombinant therapeutic enzymes ', Biotechnology and Bioengineering, vol. 118, no. 2, pp. 890-904 . https://doi.org/10.1002/bit.27621
Biotechnol Bioeng
Samoudi, M, Chung Kuo, C, Robinson, C M, Shams-Ud-Doha, K, Schinn, S-M, Kol, S, Weiss, L, Petersen Bjørn, S, Voldborg, B G, Rosa Campos, A & Lewis, N E 2021, ' In situ detection of protein interactions for recombinant therapeutic enzymes ', Biotechnology and Bioengineering, vol. 118, no. 2, pp. 890-904 . https://doi.org/10.1002/bit.27621
Despite their therapeutic potential, many protein drugs remain inaccessible to patients since they are difficult to secrete. Each recombinant protein has unique physicochemical properties and requires different machinery for proper folding, assembly,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8f0540ae6dd0a70f166b8a5419f2d2
https://doi.org/10.1101/2020.05.06.081885
https://doi.org/10.1101/2020.05.06.081885
Publikováno v:
Current Opinion in Chemical Engineering. 32:100688
Mammalian cells have been used widely as biopharmaceutical cell factories due to their ability to make complex biotherapeutic proteins with human-compatible modifications. However, their application for some products has been hampered by low protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e3503578cb5efb12f9cf349eb8773c9
https://doi.org/10.1016/j.coche.2021.100688
https://doi.org/10.1016/j.coche.2021.100688
